DE60111352D1 - Podophyllotoxin-zusammensetzungen - Google Patents

Podophyllotoxin-zusammensetzungen

Info

Publication number
DE60111352D1
DE60111352D1 DE60111352T DE60111352T DE60111352D1 DE 60111352 D1 DE60111352 D1 DE 60111352D1 DE 60111352 T DE60111352 T DE 60111352T DE 60111352 T DE60111352 T DE 60111352T DE 60111352 D1 DE60111352 D1 DE 60111352D1
Authority
DE
Germany
Prior art keywords
podophyllotoxin
compositions
discloses
present
podophylootoxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60111352T
Other languages
English (en)
Other versions
DE60111352T2 (de
Inventor
Olivier Lutz
Evgueni Klinski
Shengmin Li
Valery Alakhov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Supratek Pharma Inc
Original Assignee
Supratek Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supratek Pharma Inc filed Critical Supratek Pharma Inc
Publication of DE60111352D1 publication Critical patent/DE60111352D1/de
Application granted granted Critical
Publication of DE60111352T2 publication Critical patent/DE60111352T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
DE60111352T 2000-01-20 2001-01-11 Podophyllotoxin-zusammensetzungen Expired - Fee Related DE60111352T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48829800A 2000-01-20 2000-01-20
US488298 2000-01-20
PCT/IB2001/000087 WO2001052826A2 (en) 2000-01-20 2001-01-11 Novel podophyllotoxin compositions

Publications (2)

Publication Number Publication Date
DE60111352D1 true DE60111352D1 (de) 2005-07-14
DE60111352T2 DE60111352T2 (de) 2006-05-04

Family

ID=23939161

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111352T Expired - Fee Related DE60111352T2 (de) 2000-01-20 2001-01-11 Podophyllotoxin-zusammensetzungen

Country Status (8)

Country Link
US (1) US20060148728A1 (de)
EP (1) EP1251858B1 (de)
JP (1) JP2003520227A (de)
AT (1) ATE297209T1 (de)
AU (1) AU2001225432A1 (de)
CA (1) CA2397871A1 (de)
DE (1) DE60111352T2 (de)
WO (1) WO2001052826A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102168D0 (sv) * 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
EP1465598A4 (de) * 2001-12-21 2006-12-20 David S Soane Verwendung von oligomeren und polymeren zur solubilisierung, stabilisierung und zuführung von arzneistoffen
US7846422B2 (en) * 2003-08-04 2010-12-07 Kao Corporation Method for prevention or treatment of periodontal diseases and composition for an oral cavity
CA2574767C (en) 2004-07-19 2015-02-17 Celator Pharmaceuticals, Inc. Particulate constructs for release of active agents
US20100285141A1 (en) * 2008-01-03 2010-11-11 Do-Coop Technologies Ltd. Compositions and methods for enhancing the activity of podophyllotoxin
CA2803646A1 (en) 2010-07-02 2012-01-05 Angiochem Inc. Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
CN102423302A (zh) * 2011-11-21 2012-04-25 中国药科大学 载鬼臼苦素纳米胶束制剂和冻干制剂及其制备方法
CN102526226A (zh) * 2011-12-31 2012-07-04 沈阳药科大学 中药组方在解除肝肾毒性方面的应用
CN103304574A (zh) * 2013-03-29 2013-09-18 西南交通大学 抗癌用4’-去甲峨参内酯及其制备方法
CN104415194A (zh) * 2013-09-11 2015-03-18 罗兴富 一种治疗颈淋巴结核病的新型药物及其制备方法
US9592188B2 (en) 2014-05-22 2017-03-14 Yansong Liu Method of treating or reducing the severity of dermatological conditions
CN104435117A (zh) * 2014-12-12 2015-03-25 王正琦 一种治疗淋巴管瘤的中药组合物
CN104958547A (zh) * 2015-06-26 2015-10-07 四川金堂海纳生物医药技术研究所 一种可治疗淋巴结结核的内服消结汤及制备方法
RU2674029C1 (ru) * 2017-08-24 2018-12-04 Илья Александрович Марков Ректальные свечи и способ их приготовления (варианты)
WO2019051733A1 (zh) * 2017-09-14 2019-03-21 顾崧 一种依托泊苷胶束的制备方法
CN108552095B (zh) * 2018-03-15 2020-08-21 浙江省淡水水产研究所 一种育苗安全用水的处理方法
US11980636B2 (en) 2020-11-18 2024-05-14 Jazz Pharmaceuticals Ireland Limited Treatment of hematological disorders
CN113750255B (zh) * 2021-09-30 2023-10-31 大连民族大学 环境响应型透明质酸-鬼臼毒素前药胶束及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
WO1995030420A1 (en) * 1994-05-06 1995-11-16 Alcon Laboratories, Inc. Use of vitamin e tocopheryl derivatives in ophthalmic compositions
US5534499A (en) * 1994-05-19 1996-07-09 The University Of British Columbia Lipophilic drug derivatives for use in liposomes
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
WO1998008490A1 (en) * 1996-09-01 1998-03-05 Pharmos Corporation Solid coprecipitates for enhanced bioavailability of lipophilic substances
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
US5798333A (en) * 1996-09-17 1998-08-25 Sherman; Bernard C. Water-soluble concentrates containing cyclosporins
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US5891845A (en) * 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures
IL131217A0 (en) * 1998-03-10 2001-01-28 Napro Biotherapeutics Inc Novel methods and compositions for delivery of taxanes

Also Published As

Publication number Publication date
AU2001225432A1 (en) 2001-07-31
JP2003520227A (ja) 2003-07-02
CA2397871A1 (en) 2001-07-26
EP1251858B1 (de) 2005-06-08
EP1251858A2 (de) 2002-10-30
WO2001052826A2 (en) 2001-07-26
WO2001052826A3 (en) 2002-03-14
DE60111352T2 (de) 2006-05-04
ATE297209T1 (de) 2005-06-15
US20060148728A1 (en) 2006-07-06

Similar Documents

Publication Publication Date Title
ATE297209T1 (de) Podophyllotoxin-zusammensetzungen
BRPI0113162B8 (pt) compostos ariloxialquilaminas nao-imidazólicos e composição farmacêutica compreendendo os referidos compostos
EP1248612A4 (de) Neue substanzen und verbindungen als protease-inhibitoren
DK1157037T3 (da) GCSF-konjugater
AR022469A1 (es) Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias
AUPR213700A0 (en) Antiviral agents
DZ3402A1 (fr) Cyclopentanoindoles, compositions contenant ces composes et methodes de traitement
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
DK1087960T3 (da) Makrocykliske analoger og fremgangsmåder til deres anvendelse og fremstilling
ES2194452T3 (es) Composiciones antitranspirantes que contienen 1,2-hexanodiol.
NO20024177L (no) Farmasöytiske preparater inneholdende azetidinderivater, de nye azetidinderivater og deres fremstilling
EA200300937A1 (ru) Оральная фармацевтическая композиция цефподоксима проксетила
CO5590918A2 (es) Formulaciones
PA8495101A1 (es) Derivados de 13-metileritromicina
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
HK1111168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
GT200000001A (es) Derivados de eter propargilico novedosos.
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
DE60114640D1 (en) Antithrombosemittel
ATE218560T1 (de) Wasserlösliche ähnliche verbindungen und medicament-vorstufe von paclitaxel
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης
SE9803107D0 (sv) Novel Compunds
IT1302289B1 (it) Composizioni farmaceutiche ad attivita' antineoplastica
WO2002044403A3 (en) Markers for testing analogs of vitamin d and therapeutical uses
IL153010A0 (en) 3,3-dimethylcyclohexane derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee